Submit your comments on this article |
Economy |
New Drug Combating Wuhan Coronavirus Yield Excellent Results...And the Dow Surged Because of It |
2020-04-18 |
[Townhall] We may not have a vaccine yet, but a new drug combating the symptoms of the Wuhan coronavirus disease has yielded excellent results. The company Gilead Sciences has developed a new anti-viral for severe COVID-19 patients that was tested on 125 people selected by The University of Chicago Medicine. Most of the patients were discharged, while two sadly passed away. We need all the good news we can get as the nation has undergone a lockdown to curb the spread. Some 29 states are either going to enter the initial phases of re-opening some aspects of their respective economies or are on the cusp of doing so. That’s good. Pharmaceutical companies are moving as quickly as possible to develop better testing and treatments for COVDI-19. This drug could be added into the arsenal as an effective stopgap until we have a proper vaccine (via Stat News):Remdesivir was one of the first medicines identified as having the potential to impact SARS-CoV-2, the novel coronavirus that causes Covid-19, in lab tests. The entire world has been waiting for results from Gilead’s clinical trials, and positive results would likely lead to fast approvals by the Food and Drug Administration and other regulatory agencies. If safe and effective, it could become the first approved treatment against the disease.Another treatment being used in some places is the antimalarial drug hydroxychloroquine, which 6,000 doctors from over 30 countries ranked as the most effective against the virus. Sixty-five percent of US doctors said they would prescribe it to their family members if anyone contracted the Wuhan virus, with 67 percent saying they would take it themselves if infected. The preliminary Gilead data caused the Dow Jones to surge by almost 1,000 points today as well (via CNBC): Related: Gilead Sciences: 2020-04-17 Super-charged stocks race toward second best week ever Gilead Sciences: 2020-04-13 Gilead Sciences – The Coronavirus Vaccine Manufacturer Accused Of Bioterrorism Gilead Sciences: 2020-04-11 Two thirds of COVID-19 patients improve after Gilead drug: NEJM Related: Remdesivir: 2020-04-17 Severely Ill Patients At Chicago Hospital Showed Rapid Recovery After Receiving Gilead's Experimental Antiviral Drug Remdesivir: 2020-04-14 Coronavirus Roundup: CDC Director Says US Coronavirus Cases Stabilizing, Could Peak This Week Remdesivir: 2020-04-13 Gilead Sciences – The Coronavirus Vaccine Manufacturer Accused Of Bioterrorism |
Posted by:Besoeker |